Recent advances in neoadjuvant therapy for breast cancer

Neoadjuvant trials for early breast cancer have accelerated the identification of novel active agents, enabling streamlined conduct of registration trials with fewer subjects. Measurement of neoadjuvant drug effects has also enabled the identification of patients with high risk of distant recurrence...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Fac Rev
Hlavní autoři: Potter, David A, Herrera-Ponzanelli, César A, Hinojosa, Diego, Castillo, Rafael, Hernandez-Cruz, Irwin, Arrieta, Victor A, Franklin, Michael J, Yee, Douglas
Médium: Artigo
Jazyk:Inglês
Vydáno: Faculty Opinions Ltd 2021
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7894264/
https://ncbi.nlm.nih.gov/pubmed/33659921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12703/r/10-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky